unknown
Stage
About
Desentum Oy is a clinical-stage biopharmaceutical company developing novel allergen immunotherapy products designed to improve the efficacy, safety, and patient experience of allergy treatments.
Explore Desentum Oy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.